×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EVMN – evommune, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EVMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
04:01 pm
evmn
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Low
Report
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
2/18
02:14 pm
evmn
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Evommune (NYSE:EVMN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/12
08:30 pm
evmn
Evommune Announces $125 Million Private Placement
High
Report
Evommune Announces $125 Million Private Placement
2/10
02:13 pm
evmn
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Evommune (NYSE:EVMN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
2/10
01:32 pm
evmn
Evommune (NYSE:EVMN) had its price target raised by analysts at HC Wainwright from $35.00 to $65.00. They now have a "buy" rating on the stock.
Low
Report
Evommune (NYSE:EVMN) had its price target raised by analysts at HC Wainwright from $35.00 to $65.00. They now have a "buy" rating on the stock.
2/10
07:30 am
evmn
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis
High
Report
Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis
2/4
06:41 pm
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Weiss Ratings. They set a "sell (e)" rating on the stock.
High
Report
Evommune (NYSE:EVMN) is now covered by analysts at Weiss Ratings. They set a "sell (e)" rating on the stock.
1/22
09:00 am
evmn
Evommune (NYSE:EVMN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $42.00 price target on the stock.
Medium
Report
Evommune (NYSE:EVMN) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $42.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/5
04:09 pm
evmn
Form 10-K Evommune, Inc. For: Dec 31
Low
Report
Form 10-K Evommune, Inc. For: Dec 31
3/5
04:06 pm
evmn
Form 8-K Evommune, Inc. For: Mar 05
Low
Report
Form 8-K Evommune, Inc. For: Mar 05
2/19
04:30 pm
evmn
Form 4 Evommune, Inc. For: Feb 17 Filed by: LSP 7 Cooperative UA
Low
Report
Form 4 Evommune, Inc. For: Feb 17 Filed by: LSP 7 Cooperative UA
2/19
04:30 pm
evmn
Form SCHEDULE 13D/A Evommune, Inc. Filed by: LSP 7 Cooperative UA
Low
Report
Form SCHEDULE 13D/A Evommune, Inc. Filed by: LSP 7 Cooperative UA
2/18
09:19 pm
evmn
Form 4 Evommune, Inc. For: Feb 17 Filed by: Verduyn-van Weegen Felice Isabel
Medium
Report
Form 4 Evommune, Inc. For: Feb 17 Filed by: Verduyn-van Weegen Felice Isabel
2/17
07:29 pm
evmn
Form SCHEDULE 13D/A Evommune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Evommune, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
2/17
07:28 pm
evmn
Form 4 Evommune, Inc. For: Feb 17 Filed by: Shah Rajeev M.
Low
Report
Form 4 Evommune, Inc. For: Feb 17 Filed by: Shah Rajeev M.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: